Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Healthcare
Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Just $1.11 above IPO price of $3.50
View:
Post by GoldenInvestor on Aug 15, 2023 4:18pm

Just $1.11 above IPO price of $3.50

What has been accomplished since IPO?
Comment by Chianchin on Aug 15, 2023 6:45pm
The last IPO was at $10 do not bs
Comment by GoldenInvestor on Aug 15, 2023 10:08pm
Google search - In early March, and just two days after its shares were listed on the TSX-Venture Exchange, the company announced a $71-million financing via the sale of 20.3 million special warrants at $3.50 per warrant. As things materialized the financing ended up at $75-million after the underwriters exercised the over-allotment option. On that deal, Goodman’s private company invested ...more  
Comment by Chianchin on Aug 16, 2023 2:32am
2014, funny how this joker does not include the proper date
Comment by GoldenInvestor on Aug 16, 2023 8:30am
** date is there for those who can't do google search  Knight Therapeutics upsizes offering to $180-million  It’s been quite the journey for shareholders of Knight Therapeutics, a company that emerged this month as a result of the $1.7-billion purchase of Montreal-based Paladin Labs by U.S based Endo Health Solutions Inc.  Author of the article: Barry ...more  
Knight Therapeutics Inc